Melatonin and the Metabolic Syndrome
NCT01038921 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 39
Last updated 2015-02-27
Summary
This trial seeks to compare the effects of melatonin supplementation versus placebo in subjects with the metabolic syndrome.
Conditions
- Metabolic Syndrome
Interventions
- DRUG
-
Melatonin
8 mg dose of Melatonin
- DRUG
-
Placebo
Sponsors & Collaborators
-
Emory University
lead OTHER
Principal Investigators
-
Michael H Kutner, PhD · Emory University
-
Abinav Goyal, M.D. · Emory University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 30 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2012-06-30
- Completion
- 2013-07-31
Countries
- United States
Study Locations
More Related Trials
-
Melatonin Treatment for Induced Transient Insomnia
NCT00950885 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial on a Food Supplement With Melatonin and Herbal Products to Improve Sleep Quality
NCT05459272 ·Status: UNKNOWN ·Phase: NA
-
Melatonin Treatment for Night-Eating Syndrome
NCT02500017 ·Status: TERMINATED ·Phase: NA
-
Melatonin for Patients With Chronic Low Back Pain
NCT06859957 ·Status: RECRUITING ·Phase: PHASE3
-
Randomized Trial Investigating Melatonin Supplementation vs Placebo on Sleep Disturbance Following Total Joint Arthroplasty
NCT04590742 ·Status: UNKNOWN ·Phase: NA
-
A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia
NCT00869128 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Delirium in Intensive Care by Melatonin
NCT03524937 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort
NCT01700959 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Somnage® in the Management on Sleep and Mood in Cancer Patients
NCT02883790 ·Status: TERMINATED ·Phase: NA
-
Effect of a Novel Melatonin Supplement on Sleep Quality
NCT06215573 ·Status: COMPLETED ·Phase: NA
-
Melatonin for Sleep in MS
NCT04035889 ·Status: COMPLETED ·Phase: NA
-
Circadian Phase Adjustment and Improvement of Metabolic Control in Night Shift Workers
NCT02108353 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Orthostatic Intolerance
NCT00262470 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
NCT03000777 ·Status: COMPLETED ·Phase: NA
-
Anxiolytic and Analgesic Effects of Melatonin
NCT02386319 ·Status: COMPLETED ·Phase: PHASE3
-
Exogenous Melatonin in Intensive Care Unit Chronodisruption
NCT03708341 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of Ramelteon in Healthy Subjects
NCT00671190 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia
NCT03338764 ·Status: WITHDRAWN ·Phase: PHASE3
-
SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.
NCT03331042 ·Status: COMPLETED ·Phase: PHASE3
-
Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia
NCT03772314 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS
NCT02231008 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -Trial
NCT06252571 ·Status: RECRUITING ·Phase: PHASE2
-
Pilot Study of Melatonin and Epilepsy
NCT00965575 ·Status: COMPLETED ·Phase: PHASE2
-
Melatonin in Patients Under Carotid Endarterectomy
NCT03115034 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanisms of Sleep Latency and Health: The Effect of a Melatonin Receptor Agonist in Inflammation and Insulin Resistance
NCT02156271 ·Status: COMPLETED ·Phase: PHASE4